August 2008

Pfizer Defends Claims Against Parkinson’s Disease Drug in Bellwether MDL

North America - United States | North America | United States - Minnesota

In its first and only bellwether MDL trial, Pfizer defended claims made by plaintiffs that they failed to warn of the side effects of their drug for Parkinson’s disease. Our firm served as MDL liaison, co-trial and local counsel in Minnesota for the trial. Charbonneau v. Pfizer, Inc. et. al, No. 06-CV-1215, U.S. District Court, District of Minnesota.

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.